Ask the Experts: Exploring the Latest Evidence and Individualizing Treatment in HER2+ Metastatic Breast Cancer
Webinar/Online
Wednesday, April 23, 2025 at 2:00pm ET - 2:30pm ET
Add this event to your calendar
Info
Topic
Novel HER2-targeted therapies are transforming outcomes in HER2-positive metastatic breast cancer. Join our expert faculty as they explore the latest clinical data and treatment strategies for HER2+ breast cancer. Dive into key efficacy and safety findings, and learn how to incorporate patient- and disease-related factors into personalized care plans. Don't miss the opportunity to engage with experts and ask your burning questions!
Credits Offered
This event offers
0.5 contact hours
to attendees.
Accreditation Info:
ANCC.
Additional Information
Novel HER2-targeted therapies are transforming outcomes in HER2-positive metastatic breast cancer. Join our expert faculty as they explore the latest clinical data and treatment strategies for HER2+ breast cancer.
Speakers
Assistant Professor of Medicine
Medical Oncology
Member of the Duke Cancer Institute
Durham, NC
Dan L Duncan Professor
Department of Medicine
Section of Hematology and Oncology
Baylor College of Medicine
Houston, Texas
Executive Medical Director & Associate Director of Clinical Affairs
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medi
Adjunct Professor
Department of Pharmacotherapy
University of Utah College of Pharmacy
Salt Lake City, UT